Merck Investors Win Class Cert. In 2 Suits Over Vytorin
A New Jersey federal judge on Tuesday granted class certification in a pair of related suits brought by investors claiming drugmaker Merck & Co. and subsidiary Schering-Plough hid test results that...To view the full article, register now.
Already a subscriber? Click here to view full article